The Russian government plans to double the volume of localized active pharmaceutical ingredients (APIs) within the next five ...

Boston, USA-based neuroscience company Newleos Therapeutics has appointed Timothy Noyes as president and chief executive (CEO).

In Europe, the European Medicines Agency (EMA) was active this week with its Committee for Medicinal Products for Human Use ...

Russian drugmaker Pharmasyntez and China's Hualan Bio will join forces on the development of new drugs and technology ...

French biopharma Ipsen (Euronext: IPN) has reported a strong third quarter, with total revenue rising 9% to 915 million euros ...

Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...

German Merck KGaA’s recently acquired subsidiary SpringWorks Therapeutics today announced that long-term efficacy and safety data from the Phase III DeFi trial of Ogsiveo (nirogacestat) were in the ...

Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...

South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...

US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...

California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...